Skip to main content
. 2019 Jul-Sep;36(3):160–164. doi: 10.4103/JOC.JOC_165_18

Table 3.

Histological follow-up of Milan system diagnostic categories

Category Cat 1 Cat 2 Cat 3 Cat 4a Cat 4b Cat 5 Cat 6 Total
No. of cases 18 (6.1%) 112 (38.2%) 08 (2.7%) 98 (33.4%) 06 (2.0%) 07 (2.4%) 44 (15%) 293
No. of cases with histological follow-up 04 (2.3%) 20 (11.6%) 05 (2.9%) 90 (52.3%) 06 (3.5%) 07 (4.1%) 40 (23.2%) 172 (58.7%)
Benign: non-neoplastic 2 (50%) 13 (65%) - 01 (1.1%) 01 (16.6%) - - 17 (9.8%)
Benign: neoplastic 01 (25%) 06 (30%) 04 (80%) 85 (94.4%) 03 (50%) 01 (14.2%) 01 (2.5%) 101 (58.7%)
Malignant 01 (25%) 01 (5%) 01 (20%) 01 (4.4%) 02 (33.3%) 06 (85.7%) 39 (97.5%) 54 (31.4%)
Risk of malignancy 01/04 (25%) 01/20 (5%) 01/05 (20%) 04/90 (4.4%) 02/06 (33.3%) 06/07 (85.7%) 39/40 (97.5%) 54/172 (31.4%)